Dr. Ofobuike Okani, M.D.
What this data tells you about Dr. Okani
Dr. Ofobuike Okani is a medical oncology in Waco, TX, with 19 years in practice. Based on federal Medicare data, Dr. Okani performed 33,653 Medicare services across 1,501 unique beneficiaries.
Between the years covered by Open Payments, Dr. Okani received a total of $2,917 from 39 pharmaceutical and/or device companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Okani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 20,400 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) | 5,100 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 2,383 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,118 | $0 | $1 |
| Blood draw (venipuncture) | 1,040 | $8 | $20 |
| Complete blood count (CBC) with differential | 827 | $8 | $36 |
| Office visit, established patient (30-39 min) | 719 | $88 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 400 | $1 | $114 |
| Injection of additional new drug or substance into vein | 210 | $12 | $108 |
| Microscopic examination for white blood cells with manual cell count | 181 | $4 | $22 |
| Complete blood count (CBC), automated | 181 | $6 | $34 |
| Administration of chemotherapy into vein, 1 hour or less | 167 | $96 | $707 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 157 | $22 | $157 |
| Injection, zoledronic acid, 1 mg | 92 | $6 | $431 |
| Drug injection, under skin or into muscle | 85 | $11 | $96 |
| Administration of chemotherapy into vein, each additional hour | 82 | $21 | $161 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 79 | $46 | $313 |
| Injection, diphenhydramine hcl, up to 50 mg | 70 | $1 | $7 |
| New patient office visit, complex (60-74 min) | 57 | $153 | $709 |
| Office visit, established patient, complex (40-54 min) | 39 | $120 | $496 |
| Administration of additional new drug or substance into vein, 1 hour or less | 37 | $47 | $344 |
| Office visit, established patient (20-29 min) | 35 | $50 | $250 |
| Infusion, normal saline solution , 1000 cc | 33 | $2 | $19 |
| Unclassified drugs | 31 | $17 | $88 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 27 | $1,089 | $4,802 |
| Irrigation of implanted venous access drug delivery device | 26 | $18 | $114 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 26 | $87 | $657 |
| CT scan of abdomen and pelvis with contrast | 21 | $142 | $1,067 |
| Red blood count, automated test | 18 | $4 | $23 |
| Initial hospital admission, high complexity | 12 | $133 | $694 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Okani is a mixed practice specialist, with above-average Medicare volume (top 27% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Okani experienced with iron infusion (feraheme)?
Does Dr. Okani receive payments from pharmaceutical companies?
How do Dr. Okani's costs compare to other medical oncologys in Waco?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology